Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 5.3% in the afternoon session after its first-quarter results, although beating expectations, were overshadowed by concerns about its future ...

Recent share performance and business snapshot 10x Genomics (TXG) stock has moved sharply over recent periods, with the price down about 5% over the past week and down roughly 12% over the past month, ...

The average one-year price target for 10x Genomics (NasdaqGS:TXG) has been revised to $20.33 / share. This is an increase of 10.28% from the prior estimate of $18.43 dated February 1, 2026. The price ...

What a time it’s been for 10x Genomics. In the past six months alone, the company’s stock price has increased by a massive 73.9%, reaching $15.53 per share. This was partly thanks to its solid ...

Biotech company 10x Genomics (NASDAQ:TXG) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, but sales fell by 2.6% year on year to $150.8 million. The company expects the full year’s ...

Investors eyeing a purchase of 10x Genomics Inc (Symbol: TXG) stock, but cautious about paying the going market price of $22.36/share, might benefit from considering selling puts among the alternative ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

During the last three months, 10 analysts shared their evaluations of 10x Genomics (NASDAQ:TXG), revealing diverse outlooks from bullish to bearish. The following table provides a quick overview of ...

Looking ahead to 2030, our model projects TXG could trade at an average price of $2,836.89, with a potential range between $2,127.67 and $3,546.12. This represents a potential 11,880.1% return from ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.